Received Sep 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | OT |
patient received dose 3 of Menquadfi with no adverse event; Initial information received on 26-Aug-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves a 18 years old female patient who received dose 3 of meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in 2018, the patient received an unknown dose 1 of meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection (strength, expiry date and lot number not reported) via unknown route in unknown administration site for Immunization On an unknown date in 2023 she also received an unknown dose 2 of meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection (strength, expiry date and lot number not reported) via unknown route in unknown administration site for Immunization. On 26-Aug-2025 she also received an unknown dose 3 of meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection (strength, expiry date and lot number not reported) via unknown route in unknown administration site for Immunization (extra dose administered) (latency- same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.